All research
2026-07-01 PubMed

cGAS/STING pathway emerges as key driver of inflammation, cell death, and fibrosis in Cardiovascular Diseases

Emerging roles of the cGAS/STING pathway in cardiovascular diseases.

Background

Cardiovascular diseases (CVDs) remain the leading cause of global mortality and morbidity, necessitating novel therapeutic strategies. Inflammation is a pivotal factor in CVD pathogenesis, and the cyclic GMP-AMP synthase/stimulator of IFN genes (cGAS/STING) pathway has been increasingly implicated. This pathway recognizes both non-self and self-DNA, including mitochondrial and nuclear DNA, to activate downstream proinflammatory signaling. While circulating cell-free DNA is a known biomarker for CVDs, the precise mechanisms by which self-DNA contributes to the inflammatory signaling, cell death, and fibrosis in CVDs have been unclear.

Study Design

This review synthesizes current understanding on the roles of self-DNA and the cGAS/STING pathway in the pathophysiology of Cardiovascular Diseases (CVDs). The authors examined accumulating evidence linking cGAS/STING activation to inflammation, cell death, and fibrosis in the cardiovascular system. The review specifically discusses how various pathological stressors induce self-DNA release into the cytosol and bloodstream from damaged cells, and explores the therapeutic potential of targeting this pathway to mitigate CVD progression.

Results

The review highlights that the cGAS/STING pathway is critically involved in CVD pathogenesis by recognizing both non-self and self-DNA, including mitochondrial and nuclear DNA. This recognition activates downstream proinflammatory signaling molecules such as TANK-binding kinase 1, IFN regulatory factor 3, and NF-κB. > Accumulating evidence implicates the cGAS/STING pathway in driving inflammation, cell death, and fibrosis characteristic of CVDs. Pathological stressors in the cardiovascular system lead to self-DNA release into the cytosol and bloodstream, which serves as a useful biomarker for CVDs. The pathway's activation contributes to the inflammatory cascade and cellular damage observed in various CVDs, underscoring its central role in disease progression.

Key Findings

  • The cGAS/STING pathway is a key mediator of inflammation in Cardiovascular Diseases (CVDs).
  • The pathway recognizes both non-self and self-DNA, including mitochondrial and nuclear DNA.
  • Activation of cGAS/STING leads to downstream proinflammatory signaling via NF-κB and IFN regulatory factor 3.
  • Pathological stressors induce self-DNA release, which acts as a biomarker and contributor to CVDs.
  • Targeting the cGAS/STING pathway holds therapeutic potential for mitigating CVD pathogenesis.

Why It Matters

This review consolidates evidence positioning the cGAS/STING pathway as a fundamental driver of Cardiovascular Diseases (CVDs), shifting focus towards a novel therapeutic target. Targeting the cGAS/STING pathway could offer a new strategy to combat inflammation, cell death, and fibrosis in CVDs, potentially improving patient outcomes where current treatments fall short. For biohackers and clinicians, understanding this pathway opens avenues for exploring interventions that modulate DNA-sensing immunity, moving beyond traditional anti-inflammatory approaches. While still preclinical, this research indicates a promising direction for future drug development and personalized medicine in cardiovascular health.


cgas-sting cardiovascular-disease inflammation self-dna nf-kb fibrosis
Source: pubmed:42383351 · Ingested 2026-07-01 · Digest: gemini-2.5-flash